References
- Ackrill P, Ralston AJ, Day JP, Hodge KC. Successful removal of aluminium from patient with dialysis encephalopathy. Lancet 1980; ii: 692–693.
- Alfrey AC, Mishell JJ, Burks J, Contigulia SR, Rudolph H, Lewin E, Holmes JH. Syndrome of dyspraxia and multifocal seizures associated with chronic haemo-dialysis. Trans Am Soc Artif Inter Organs 1972; 18: 257–261.
- Brown DJ, Harn KN, Dawborn JK, Xipell JM. Treatment of dialysis osteomalacia with desferrioxamine. Lancet 1982; ii: 343–345.
- Day JP. Chemical aspects of aluminium chelation by desferrioxamine. In: Taylor, ed. Aluminium and other trace elements in renal disease. Baillière Tindall, 1986: 184- 192.
- Day JP, Ackrill P, Garstang FM et al. Reduction of the body burden of aluminium in renal patients by desferrioxamine chelation therapy. In: Brown SS, Savory J, eds. Chemical Toxicology and clinical chemistry of metals. Academic Press, 1983: 353–356.
- Kim YS, Lee MH, Wisniewski HM. Aluminium induced reversible change in permeability of blood brain barrier to (14c) sucrose. Brain Res 1986; 377: 286–291.
- Milliner DS, Alfrey AC, Sherrard DJ, Ott SM, Shinaberger JH, Nissenson AR, Coburn JW. Response of desferrioxamine infusion in patients with dialysis osteomalacia. (Abstract.) Symposium on Clinical Disorder of Bone and Mineral Metabolism. Detroit, 1983.
- Winney RJ, Kean DM, Best JJK, Smith MA. Changes in brain water with haemodialysis. Lancet 1986; ii: 1107–1108.